A CONTROLLED CLINICAL-TRIAL OF BACLOFEN AS PROTECTIVE THERAPY IN EARLY HUNTINGTONS-DISEASE

被引:81
作者
SHOULSON, I
ODOROFF, C
OAKES, D
BEHR, J
GOLDBLATT, D
CAINE, E
KENNEDY, J
MILLER, C
BAMFORD, K
RUBIN, A
PLUMB, S
KURLAN, R
机构
[1] UNIV ROCHESTER,MED CTR,DEPT PSYCHIAT,ROCHESTER,NY 14642
[2] UNIV ROCHESTER,MED CTR,DIV BIOSTAT,ROCHESTER,NY 14642
关键词
D O I
10.1002/ana.410250308
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:252 / 259
页数:8
相关论文
共 44 条
[1]  
ANDEN NE, 1973, LANCET, V2, P93
[2]  
ARMITAGE P, 1971, STATISTICAL METHODS, P331
[3]  
BAMFORD K, 1986, NEUROLOGY, V36, P102
[4]   COMPARATIVE NEUROLOGICAL AND ANTICONVULSANT EFFECTS OF BACLOFEN (BF), MUSCIMOL (MC), DIAZEPAM (DZ) AND GAMMA-BUTYROLACTONE (GBL) [J].
BERNARD, PS ;
SOBISKI, R ;
DAWSON, K .
BRAIN RESEARCH BULLETIN, 1979, 4 (05) :695-695
[5]  
BORISON RL, 1979, ANN NEUROL, V6, P149
[6]  
CHOI DW, 1988, J NEUROSCI, V8, P185
[7]  
COLTON T, 1974, STAT MED, P99
[8]   NONCHOLINERGIC SYNAPTIC EXCITATION IN NEOSTRIATUM - PHARMACOLOGICAL EVIDENCE FOR MEDIATION BY A GLUTAMATE-LIKE TRANSMITTER [J].
CORDINGLEY, GE ;
WEIGHT, FF .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (04) :847-856
[9]  
COX DR, 1984, ANAL SURVIVAL DATA, V0021